La chaîne d'options affiche les données clés des options sur actions de Amentum Holdings à différents prix d'exercice et dates d'expiration. Les traders utilisent ces informations pour analyser les transactions potentielles et évaluer le sentiment du marché pour Amentum Holdings..

Amentum Holdings (NYSE:AMTM) Stock, Chaîne d'Options

AMENTUM HOLDINGS INC

Amentum Holdings

Amentum Holdings Inc is engaged in engineering and technology solutions. The United States and its allies trust it to address their technical and complex scientific, security, and sustainability challenges.

Amentum Holdings Inc

<p><a href="https://www.bloomberg.com/news/articles/2025-04-01/how-meta-s-upcoming-1000-smart-glasses-with-a-screen-will-work?srnd=homepage-americas" title="https://www.bloomberg.com/news/articles/2025-04-01/how-meta-s-upcoming-1000-smart-glasses-with-a-screen-will-work?srnd=homepage-americas">https://www.bloomberg.com/news/articles/2025-04-01/how-meta-s-upcoming-1000-smart-glasses-with-a-screen-will-work?srnd=homepage-americas</a></p>


News

'How Meta's Upcoming $1000+ Smart Glasses With A Screen Will Work' - Bloomberg

<p><strong>AMC Entertainment Hldgs's</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMC#NYSE">AMC</a>) short percent of float has risen 3.41% since its last report. The company recently reported that it has <strong>39.23 million shares sold short</strong>, which is 9.1% of all regular shares that are available for trading. Based on its trading volume, <strong>it would take traders 4.95 days to cover their short positions on average.</strong></p>
<h3>Why Short Interest Matters</h3>
<p>Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.</p>
<p>Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.</p>
<p><strong>See Also:</strong> <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage"><strong>List of the most shorted stocks</strong></a></p>
<h3>AMC Entertainment Hldgs Short Interest Graph (3 Months)</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1743534926_0.png" alt="short_fig" /></p>
<p>As you can see from the chart above the percentage of shares that are sold short for AMC Entertainment Hldgs has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.</p>
<h3>Comparing AMC Entertainment Hldgs's Short Interest Against Its Peers</h3>
<p>Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.</p>
<p>According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, AMC Entertainment Hldgs's peer group average for short interest as a percentage of float is 7.62%, which means the company has <strong>more</strong> short interest than most of its peers.</p>
<p>Did you know that increasing short interest can actually be <strong>bullish</strong> for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage"><strong>This post by Benzinga Money explains how you can profit from it.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and was reviewed by an editor.</em></p>


Short Sellers

Short Ideas

Trading Ideas

How Do Investors Really Feel About AMC Entertainment Hldgs?

<p><strong>Ameriprise Finl's</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMP#NYSE">AMP</a>) short percent of float has fallen 14.55% since its last report. The company recently reported that it has <strong>1.16 million shares sold short</strong>, which is 1.41% of all regular shares that are available for trading. Based on its trading volume, <strong>it would take traders 1.96 days to cover their short positions on average.</strong></p>
<h3>Why Short Interest Matters</h3>
<p>Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.</p>
<p>Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.</p>
<p><strong>See Also:</strong> <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage"><strong>List of the most shorted stocks</strong></a></p>
<h3>Ameriprise Finl Short Interest Graph (3 Months)</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1743534921_0.png" alt="short_fig" /></p>
<p>As you can see from the chart above the percentage of shares that are sold short for Ameriprise Finl has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.</p>
<h3>Comparing Ameriprise Finl's Short Interest Against Its Peers</h3>
<p>Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.</p>
<p>According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Ameriprise Finl's peer group average for short interest as a percentage of float is 3.49%, which means the company has <strong>less</strong> short interest than most of its peers.</p>
<p>Did you know that increasing short interest can actually be <strong>bullish</strong> for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage"><strong>This post by Benzinga Money explains how you can profit from it.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and was reviewed by an editor.</em></p>


Looking Into Ameriprise Finl's Recent Short Interest

WIIM

Johnson & Johnson shares are trading lower after a Federal Judge rejected the company's subsidiary Red River Talc's request to approve its prepackaged bankruptcy plan.

<p><strong>First Solar's</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FSLR#NYSE">FSLR</a>) short percent of float has risen 8.57% since its last report. The company recently reported that it has <strong>8.18 million shares sold short</strong>, which is 10.01% of all regular shares that are available for trading. Based on its trading volume, <strong>it would take traders 2.61 days to cover their short positions on average.</strong></p>
<h3>Why Short Interest Matters</h3>
<p>Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.</p>
<p>Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.</p>
<p><strong>See Also:</strong> <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage"><strong>List of the most shorted stocks</strong></a></p>
<h3>First Solar Short Interest Graph (3 Months)</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1743534915_0.png" alt="short_fig" /></p>
<p>As you can see from the chart above the percentage of shares that are sold short for First Solar has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.</p>
<h3>Comparing First Solar's Short Interest Against Its Peers</h3>
<p>Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.</p>
<p>According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, First Solar's peer group average for short interest as a percentage of float is 5.32%, which means the company has <strong>more</strong> short interest than most of its peers.</p>
<p>Did you know that increasing short interest can actually be <strong>bullish</strong> for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage"><strong>This post by Benzinga Money explains how you can profit from it.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and was reviewed by an editor.</em></p>


FSLR

Looking Into First Solar's Recent Short Interest

<p><a href="https://www.ft.com/content/ad7fcc22-343e-47e3-a6f3-58bfd4294c9d" title="https://www.ft.com/content/ad7fcc22-343e-47e3-a6f3-58bfd4294c9d">https://www.ft.com/content/ad7fcc22-343e-47e3-a6f3-58bfd4294c9d</a></p>


Legal

AAPL

'US Labour Watchdog Halts Apple Cases After Donald Trump Picks Group's Lawyer For Top Job' - Financial Times

<p>When then GOP presidential candidate <a href="https://www.benzinga.com/topic/donald-trump"><strong>Donald Trump</strong></a> ran against his Democrat and pro-weed rival <a href="https://www.benzinga.com/topic/kamala-harris"><strong>Kamala Harris</strong></a>, he said he supported rescheduling cannabis. While some considered his comments purely campaign talk, it seems clear the president is not in a hurry to make any significant changes to cannabis policy.</p>
<h2 class="wp-block-heading"><strong>How Do We Know That?</strong></h2>
<p>A White House official <a href="https://www.cnn.com/2025/04/01/politics/trump-marijuana-ads/index.html">told CNN</a> in a report published on Tuesday that "no action is being considered at this time" as far as marijuana policy is concerned.</p>
<p>The outlet also pointed out that talks about cannabis reform stalled well before the White House discussed the confirmation of Attorney General <strong>Pam Bondi</strong>, who now oversees the DEA as head of the Department of Justice.</p>
<p>Bondi, who replaced weed advocate and former Rep. <strong>Matt Gaetz</strong> when he <a href="https://www.benzinga.com/markets/cannabis/24/12/42655999/house-ethics-committee-alleges-matt-gaetz-violated-laws-releases-report-on-misconduct">ran into trouble </a>with the House Ethics Committee, is far less supportive of marijuana reforms. &nbsp;</p>
<h2 class="wp-block-heading">&#8216;<strong>The Enemy Of My Enemy Is My Friend</strong>&#8216;</h2>
<p>Meanwhile, a pro-weed group &#8211; the American Rights and Reform PAC- is launching a million-dollar ad campaign to win Trump's favor.</p>
<p>Echoing the proverb &#8220;the enemy of my enemy is my friend,&#8221; the group is criticizing both former President <strong>Joe Biden</strong> and Canada—frequent targets of Trump's political rhetoric.</p>
<p>In one ad, says CNN, the group attacks Biden for not fulfilling his promise to reschedule marijuana and the other takes a dig at our Northern neighbor for having the nerve to "cash in" on Washington's anti-weed policies by allowing American companies to list on Canada's stock market.</p>
<p>The group's two ads praise Trump for supporting access to experimental treatments in his first term in the White House, referring to the Right to Try Act.</p>
<p>According to CNN, a lobbyist for <strong>Curaleaf Holdings Inc.</strong> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CURLF#OTC">CURLF</a>) is listed as the organization's treasurer.</p>
<p>The two 30-second spots will air throughout April in Washington, DC and in the Florida media market near Mar-a-Lago, Trump's Palm Beach mansion, a person familiar with the super PAC's plans told CNN. &nbsp;</p>
<p><strong>Here&#8217;s a sneak peek at one of the ads</strong>:</p>
<p><figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"><br />
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="American Rights and Reform PAC Cannabis Reform Ad #shorts" width="500" height="281" src="https://www.youtube.com/embed/OhmLDr_WN_4?feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
<p></p></figure></p>
<p><strong>Now Read:</strong></p>
<ul>
<li><a href="https://www.benzinga.com/markets/cannabis/25/03/44543635/trump-links-cannabis-decriminalization-to-disorder-in-dc-establishes-law-enforcement-task-force"><strong>Trump Links Cannabis Decriminalization To &#8216;Disorder&#8217; In DC, Establishes Law Enforcement Task Force</strong></a></li>
</ul>
<p><em>Photo: Shutterstock</em></p>


Cannabis

Government

Politics

CURALEAF HLDGS INC by Curaleaf Hldgs Inc.

CURLF

Trump Gets Fawning Praise From Pro-Cannabis PAC But He's Not Returning The Sentiment

<p>Attorney General <strong>Pam Bondi</strong> <a href="https://www.justice.gov/opa/pr/attorney-general-pamela-bondi-directs-prosecutors-seek-death-penalty-luigi-mangione">announced</a> today that federal prosecutors will seek the death penalty against <strong>Luigi Mangione</strong>, the 26-year-old accused of murdering a <strong>UnitedHealthcare</strong> <strong>Group Inc</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>) executive in what authorities call a <a href="https://www.justice.gov/opa/pr/attorney-general-pamela-bondi-directs-prosecutors-seek-death-penalty-luigi-mangione">politically motivated assassination</a>.</p>
<p><strong>What To Know:</strong> Bondi described the Dec. 4, 2024, killing of <strong>Brian Thompson</strong> as a "premeditated, cold-blooded assassination" and reaffirmed her commitment to <a href="https://www.justice.gov/ag/media/1388561/dl?inline=&amp;utm_medium=email&amp;utm_source=govdelivery">restoring</a> the federal death penalty. </p>
<p>"Mangione's actions shocked America," Bondi stated, emphasizing that the move aligns with President Trump's agenda to combat violent crime.</p>
<p>Mangione, who grew up in a wealthy Baltimore real estate family, allegedly targeted Thompson as part of a broader statement against the healthcare industry. Authorities <a href="https://www.benzinga.com/markets/24/12/42512814/luigi-mangione-lived-a-privileged-life-of-real-estate-wealth-before-arrest-in-ceo-case">found a manifesto</a> detailing his grievances, along with a 3D-printed gun and silencer at the time of his arrest.</p>
<p>Federal charges against Mangione were filed on Dec. 19. Bondi has now instructed Acting U.S. Attorney <strong>Matthew Podolsky</strong> to pursue the death penalty.</p>
<p>The case has meanwhile sparked public debate, with some supporters criticizing the healthcare sector and <a href="https://in.benzinga.com/news/legal/25/02/43887520/luigi-mangione-back-in-court-friday-supporters-donate-500k-to-suspected-killer">donating over $514,000</a> to Mangione's legal defense fund.</p>
<p><strong>Read Also: <a href="https://www.benzinga.com/government/regulations/25/04/44591525/wall-street-inches-up-ahead-of-tariff-day-whats-driving-markets-tuesday">Wall Street Inches Up Ahead Of Tariff Day: What&#8217;s Driving Markets Tuesday?</a></strong></p>
<p><strong>What Else:</strong> The US Attorney General&#8217;s office on Feb. 5 announced the <a href="https://www.justice.gov/ag/media/1388561/dl?inline=&amp;utm_medium=email&amp;utm_source=govdelivery">revival</a> of the federal death penalty, immediately lifting the moratorium on federal executions.</p>
<p>According to the memo, federal prosecutors are now directed to actively seek the death penalty in cases involving offenses such as the murder of law enforcement officers and capital crimes committed by undocumented individuals.  &nbsp;</p>
<p>This policy shift also includes a review of past decisions where the death penalty was not pursued, indicating a firm stance on capital punishment. The federal government will also assist states in implementing death sentences.</p>
<p>As Mangione's trial continues, Bondi's strong support for capital punishment will likely remain a key focus, highlighting the administration's tough-on-crime policies.</p>
<p><strong>Read Also</strong></p>
<ul>
<li><strong><a href="https://www.benzinga.com/government/regulations/25/04/44584000/veteran-investor-warns-of-rising-stagflation-risk-as-tariffs-loom-anticipates-squeezed-profit-margins-for-us-businesses">Veteran Investor Warns Of Rising Stagflation Risk As Tariffs Loom, Anticipates &#8216;Squeezed Profit Margins&#8217; For US Businesses</a></strong></li>
</ul>


AG Pam Bondi Seeks Death Penalty For UnitedHealthcare Exec's Murder

<p>As <strong>MicroStrategy Inc.</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSTR#NASDAQ">MSTR</a>) increases its Bitcoin purchases, investors now have a new vehicle to hedge against future declines. YieldMax has introduced the <strong>YieldMax MSTR Short Option Income Strategy ETF </strong>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WNTR#NYSE">WNTR</a>), an <a href="https://www.benzinga.com/etfs">actively managed ETF</a> that seeks to benefit from MSTR stock price decreases while providing monthly income.</p>
<p>This is YieldMax&#8217;s 46th options strategy ETF and the fifth in the company&#8217;s expanding roster. The timing is interesting, as MSTR has just increased its Bitcoin holding, adding even more to its exposure to the cryptocurrency&#8217;s volatility. For those worried about contemplated price corrections, WNTR is a structured means to avoid downside risk.</p>
<p><strong>Also Read: <a href="https://www.benzinga.com/etfs/specialty-etfs/25/03/44572706/value-stocks-gain-ground-as-inflation-recession-fears-grow-4-etfs-to-capitalize-on-the-trend">Value Stocks Gain Ground As Inflation, Recession Fears Grow: 4 ETFs To Capitalize On The Trend</a></strong></p>
<p>WNTR uses a synthetic-covered put strategy to offer inverse exposure to MSTR, i.e., it profits when the stock price goes down—but only to some extent. However, the potential upside from MSTR&#8217;s dips are capped when the stock declines considerably, as per the prospectus of the fund.</p>
<p>Where WNTR&#8217;s managers expect a sharp decline, the fund can pursue an alternative strategy through selling credit put spreads. This <a href="https://cbs4indy.com/business/press-releases/globenewswire/9411979/yieldmax-introduces-short-option-income-strategy-etf-on-microstrategy-inc-mstr/">strategy </a>maximizes potential returns while preserving inverse downside capture. The fund can also buy out-of-the-money calls as a hedge against surprise price rebounds.</p>
<p>The ETF has an expense ratio of 1.01% and collateralizes its covered put positions in U.S. Treasuries. In addition to supporting the strategy of the fund, these holdings also make their way into the fund&#8217;s monthly income distributions—a big draw for investors looking for consistent returns.</p>
<p>YieldMax has been adding to its lineup of options-based exchange-traded funds (ETFs), with WNTR being added to other strategies with Tesla, Coinbase, NVIDIA and the Nasdaq-100 Index. The $2.5 billion YieldMax MSTR Option Income Strategy ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MSTY#NYSE">MSTY</a>) is its largest ETF yet, and it employs a covered call approach to MSTR.</p>
<p><strong>Read Next: </strong></p>
<ul>
<li><strong><a href="https://www.benzinga.com/25/03/44576678/cathie-wood-defies-coreweave-ipo-slump-ark-snaps-up-3-6-million-worth-of-stock-in-nvidia-backed-company">Cathie Wood Defies CoreWeave IPO Slump, Ark Snaps Up $3.6 Million Worth Of Stock In Nvidia-Backed Company</a></strong></li>
</ul>
<p><em>Photo: Shutterstock</em></p>


Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

New ETFs

ETFs

MSTR

Tidal Trust II YieldMax MSTR Option Income Strategy ETF

MSTY

WNTR

YieldMax Unveils WNTR ETF Amid MicroStrategy's Expanding Bitcoin Bet

<p>First-quarter delivery figures from <strong>Tesla Inc</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) could be more anticipated than usual, given intense concerns for demand amid boycotts and lower sales reported in <a href="https://www.benzinga.com/news/global/25/03/44128646/tesla-sales-drop-in-europe-in-february-some-countries-down-over-40-is-musks-political-push-hurting-ev-company">regions in Europe.</a></p>
<p>Here's a look at key estimates before Tesla reports first-quarter deliveries this week.</p>
<p><strong>What Happened</strong>: President <strong>Donald Trump</strong> <a href="https://www.benzinga.com/general/education/25/03/44289061/why-trumps-new-tesla-wont-be-hitting-the-open-road">purchased a Tesla vehicle</a> in the first quarter of 2025. Now, investors and analysts are closely watching for official delivery figures to see how many thousands of customers worldwide also received their Teslas during the quarter.</p>
<p>Consensus estimates from analysts compiled by Tesla are for first-quarter deliveries of 377,592 units, as reported by Teslarati. This figure comprises 351,893 Model 3/Model Y and 21,241 deliveries of other Tesla models.</p>
<p>Tesla influencer <strong>Sawyer Merritt </strong>recently conducted a <a href="https://x.com/SawyerMerritt/status/1906740457050181944">poll </a>of followers on X for their predictions on how many vehicles Tesla will deliver in the first quarter. Here are the results from over 10,000 X users:</p>
<ul>
<li>Under 350,000: 37.3%</li>
<li>350,000 to 360,000: 31.4%</li>
<li>360,000 to 370,000: 11.9%</li>
<li>More than 370,000: 19.4%</li>
</ul>
<p>The under 350,000 option was the leading vote getter at 37.3% followed by the 350,000 to 360,000 range at 31.4%. In total, 68.7% of respondents see Tesla reporting 360,000 or less deliveries in the first quarter.</p>
<p><strong>Troy Teslike,</strong> who predicts Tesla deliveries and production figures, <a href="https://x.com/TroyTeslike/status/1906829878592524446">shared </a>his final prediction for the quarter on X. Teslike predicts Tesla will have deliveries of 355,000 units in the first quarter.</p>
<p>On the prediction platform <strong>Kalshi</strong>, users can wager on Tesla's delivery totals by trading in binary markets—each representing a specific delivery range. Traders buy "Yes" or "No" contracts, with each correct prediction paying out $1.</p>
<p><iframe loading="lazy" src="https://kalshi.com/external-widgets/events/KXTESLA-25-Q1?color_scheme=light&#038;widget_size=medium&#038;variant=a&#038;ids=KXTESLA-25-Q1-270000&#038;ids=KXTESLA-25-Q1-310000&#038;ids=KXTESLA-25-Q1-330000" width="488px" height="196px" style="border:0"></iframe></p>
<p>On Kalshi, the odds of 310,000 deliveries or more and 330,000 deliveries or more have odds of 95% and 94%, respectively. After that,t the odds slide significantly. For 340,000 deliveries, 86% of bettors see this figure as likely to happen, or the equivalent of an 86 cent bet on yes, which would pay out $1 if it is right. For 350,000 deliveries or more, the odds are 56%, paying out a profit of 44 cents on a yes bet of $1 if the company can pass that figure.</p>
<p><strong>Read Also: <a href="https://www.benzinga.com/interview/25/03/44539183/exclusive-tesla-protest-organizer-says-elon-musk-seems-to-have-purchased-the-american-government">EXCLUSIVE: Tesla Protest Organizer Says &#8216;Elon Musk Seems To Have Purchased The American Government&#8217;</a></strong></p>
<p><strong>Why It's Important: </strong>Tesla reported first-quarter deliveries of 386,810 last year. The electric vehicle company is likely to come under that figure to start 2025 and below analyst estimates, which could be in part due to the political push by Tesla CEO <strong>Elon Musk.</strong> </p>
<p>The company said it expects its vehicle business to return to growth in 2025, but it could start off on the wrong foot and be counting on a strong second half of the year with catalysts ahead.</p>
<p>Reports of lower-than-expected sales of Tesla vehicles in regions in Europe have likely led to lower estimates. In China, Tesla registrations could be picking up, according to a report from <a href="https://www.teslarati.com/tesla-china-registrations-highest-q1-final-week/">Teslarati</a>.</p>
<p>The week of March 24 through March 30 had 20,700 Tesla vehicles registered in China, the highest reported figure for the quarter, according to reports. The strong delivery figures come after January and February, which had low deliveries before a rebound in late February and early March, helped by the introduction of the new Model Y in the country.</p>
<p>Musk's push into politics has hurt the brand value of Tesla and led to polls showing people are less likely to buy Tesla vehicles in the future. While this could mean weak first-quarter sales, it could become an even bigger storyline into the rest of 2025.</p>
<p>Benzinga <a href="https://www.benzinga.com/25/03/44360899/exclusive-trumps-tesla-purchase-unlikely-to-boost-sales-as-53-say-never">recently polled readers </a>on if they would buy a Tesla vehicle.</p>
<p>"Donald Trump recently bought a Tesla. How does this affect your view of Tesla?" Benzinga asked.</p>
<p>Here were the results:</p>
<ul>
<li><strong>I will never own a Tesla</strong>: 53%</li>
<li><strong>I'm more likely to buy a Tesla:</strong>&nbsp;23%</li>
<li><strong>I'm less likely to buy a Tesla</strong>: 14%</li>
<li><strong>I already own a Tesla</strong>: 10%</li>
</ul>
<p>The poll may have some bad news for Tesla fans and investors with the majority saying they will never own a Tesla vehicle.</p>
<p>The good news is that of undecided non-Tesla owners, 23% said they are more likely to buy a Tesla, while 14% said they are less likely to buy a Tesla on account of Trump's purchase and sales pitch for the EV company.</p>
<p>A low delivery figure reported this week could amplify concerns about the demand for Tesla vehicles and lead to lower shares and analysts cutting their price targets.</p>
<p><strong>TSLA Price Action</strong>: Tesla is up 3.7% to $268.82 on Tuesday versus a 52-week trading range of $138.80 to $488.54. Tesla stock is down 27.5% year-to-date in 2025 and up 56.9% over the last year.</p>
<p><strong>Read Next: </strong></p>
<ul>
<li><strong><a href="https://www.benzinga.com/news/earnings/25/01/43321103/tesla-q4-earnings-highlights-revenue-miss-eps-miss-ev-updates-automaker-says-2025-will-be-a-seminal-year">Tesla Q4 Earnings Highlights: Revenue Miss, EPS Miss, EV Updates, Automaker Says &#8216;2025 Will Be A Seminal Year&#8217;</a></strong></li>
</ul>
<p><em>Photo: Shutterstock</em></p>


Previews

TSLA

Tesla Q1 Deliveries Preview: Analysts Forecast 377K, But Kalshi Traders Predict A Miss

WF International shares are trading higher after the company launched its IPO.

<p>Whales with a lot of money to spend have taken a noticeably bearish stance on <strong>Cheniere Energy</strong>.</p>
<p>Looking at options history for Cheniere Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LNG#NYSE">LNG</a>) we detected 10 trades.</p>
<p>If we consider the specifics of each trade, it is accurate to state that 40% of the investors opened trades with bullish expectations and 50% with bearish.</p>
<p>From the overall spotted trades, 3 are puts, for a total amount of $238,910 and 7, calls, for a total amount of $1,697,999.</p>
<h3>Expected Price Movements</h3>
<p>Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $220.0 to $240.0 for Cheniere Energy during the past quarter. </p>
<h3>Volume &amp; Open Interest Development</h3>
<p>In terms of liquidity and interest, the mean open interest for Cheniere Energy options trades today is 1097.57 with a total volume of 3,783.00.</p>
<p>In the following chart, we are able to follow the development of volume and open interest of call and put options for Cheniere Energy's big money trades within a strike price range of $220.0 to $240.0 over the last 30 days.</p>
<h3>Cheniere Energy Call and Put Volume: 30-Day Overview</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1743534124_0.png" alt="Options Call Chart" /></p>
<h3>Biggest Options Spotted:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th align="right"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>LNG</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$23.4</td>
<td>$22.8</td>
<td>$22.8</td>
<td>$240.00</td>
<td>$1.3M</td>
<td>617</td>
<td align="right">600</td>
</tr>
<tr>
<td>LNG</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$29.1</td>
<td>$27.1</td>
<td>$27.6</td>
<td>$240.00</td>
<td>$168.3K</td>
<td>112</td>
<td align="right">66</td>
</tr>
<tr>
<td>LNG</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>03/20/26</td>
<td>$28.2</td>
<td>$26.6</td>
<td>$26.6</td>
<td>$240.00</td>
<td>$143.6K</td>
<td>32</td>
<td align="right">51</td>
</tr>
<tr>
<td>LNG</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>04/17/25</td>
<td>$2.8</td>
<td>$2.6</td>
<td>$2.6</td>
<td>$240.00</td>
<td>$46.8K</td>
<td>3.9K</td>
<td align="right">459</td>
</tr>
<tr>
<td>LNG</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>04/17/25</td>
<td>$2.8</td>
<td>$2.6</td>
<td>$2.6</td>
<td>$240.00</td>
<td>$46.8K</td>
<td>3.9K</td>
<td align="right">819</td>
</tr>
</tbody>
</table>
</p>
<h3>About Cheniere Energy</h3>
<p>Cheniere Energy is a liquified natural gas, or LNG, producer with two facilities in Corpus Christi, Texas and Sabine Pass, Louisiana. It generates most of its revenue through long-term contracts with customers on a fixed and variable fee payout structure. It also generates revenue by selling uncontracted LNG to customers on a short or one-time basis. A subsidiary, Cheniere Energy Partners, owns the Sabine Pass facility and trades as a master limited partnership.</p>
<p>After a thorough review of the options trading surrounding Cheniere Energy, we move to examine the company in more detail. This includes an assessment of its current market status and performance.</p>
<h3>Cheniere Energy's Current Market Status</h3>
<ul>
<li>Currently trading with a volume of 790,276, the LNG's price is down by 0.0%, now at $231.4. </li>
<li>RSI readings suggest the stock is currently may be approaching overbought.</li>
<li>Anticipated earnings release is in 31 days.</li>
</ul>
<h3>What Analysts Are Saying About Cheniere Energy</h3>
<p>2 market experts have recently issued ratings for this stock, with a consensus target price of $254.0.</p>
<p><strong>Turn $1000 into $1270 in just 20 days?</strong></p>
<p>20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage"><strong>Click here for access</strong></a>.<br />
&#x2A; An analyst from Mizuho has decided to maintain their Outperform rating on Cheniere Energy, which currently sits at a price target of $254.<br />
&#x2A; Consistent in their evaluation, an analyst from Scotiabank keeps a Sector Outperform rating on Cheniere Energy with a target price of $254. </p>
<p>Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Cheniere Energy options trades with real-time alerts from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.</p>


Options

Markets

Cheniere Energy's Options Frenzy: What You Need to Know

<p>Deep-pocketed investors have adopted a bearish approach towards Accenture (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ACN#NYSE">ACN</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in ACN usually suggests something big is about to happen.</p>
<p>We gleaned this information from our observations today when Benzinga's options scanner highlighted 17 extraordinary options activities for Accenture. This level of activity is out of the ordinary.</p>
<p>The general mood among these heavyweight investors is divided, with 41% leaning bullish and 52% bearish. Among these notable options, 5 are puts, totaling $211,082, and 12 are calls, amounting to $12,677,230.</p>
<h3>Expected Price Movements</h3>
<p>Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $260.0 to $360.0 for Accenture during the past quarter. </p>
<h3>Analyzing Volume &amp; Open Interest</h3>
<p>In today's trading context, the average open interest for options of Accenture stands at 115.11, with a total volume reaching 7,652.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Accenture, situated within the strike price corridor from $260.0 to $360.0, throughout the last 30 days.</p>
<h3>Accenture 30-Day Option Volume &amp; Interest Snapshot</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1743534118_0.png" alt="Options Call Chart" /></p>
<h3>Significant Options Trades Detected:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th align="right"><strong>Open Interest</strong></th>
<th><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>ACN</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/15/27</td>
<td>$51.7</td>
<td>$49.5</td>
<td>$51.2</td>
<td>$310.00</td>
<td>$7.1M</td>
<td align="right">12</td>
<td>2.3K</td>
</tr>
<tr>
<td>ACN</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/15/27</td>
<td>$51.7</td>
<td>$49.5</td>
<td>$51.2</td>
<td>$310.00</td>
<td>$4.8M</td>
<td align="right">12</td>
<td>2.3K</td>
</tr>
<tr>
<td>ACN</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/15/27</td>
<td>$51.1</td>
<td>$48.6</td>
<td>$51.0</td>
<td>$310.00</td>
<td>$255.0K</td>
<td align="right">12</td>
<td>2.3K</td>
</tr>
<tr>
<td>ACN</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>03/20/26</td>
<td>$33.3</td>
<td>$32.6</td>
<td>$32.6</td>
<td>$320.00</td>
<td>$91.2K</td>
<td align="right">42</td>
<td>39</td>
</tr>
<tr>
<td>ACN</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$15.6</td>
<td>$15.5</td>
<td>$15.5</td>
<td>$315.00</td>
<td>$69.7K</td>
<td align="right">8</td>
<td>61</td>
</tr>
</tbody>
</table>
</p>
<h3>About Accenture</h3>
<p>Accenture is a leading global IT services firm that provides consulting, strategy, and technology and operational services. These services run the gamut from aiding enterprises with digital transformation to procurement services to software system integration. The company provides its IT offerings to a variety of sectors, including communications, media and technology, financial services, health and public services, consumer products, and resources. Accenture employs just under 500,000 people throughout 200 cities in 51 countries.</p>
<p>In light of the recent options history for Accenture, it's now appropriate to focus on the company itself. We aim to explore its current performance.</p>
<h3>Where Is Accenture Standing Right Now?</h3>
<ul>
<li>With a volume of 2,095,171, the price of ACN is down -0.14% at $311.61. </li>
<li>RSI indicators hint that the underlying stock may be approaching oversold.</li>
<li>Next earnings are expected to be released in 80 days.</li>
</ul>
<h3>Professional Analyst Ratings for Accenture</h3>
<p>Over the past month, 5 industry analysts have shared their insights on this stock, proposing an average target price of $388.6.</p>
<p><strong>Unusual Options Activity Detected: Smart Money on the Move</strong></p>
<p>Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage"><strong>Click here for access</strong></a>.<br />
&#x2A; An analyst from Mizuho persists with their Outperform rating on Accenture, maintaining a target price of $398.<br />
&#x2A; Maintaining their stance, an analyst from Piper Sandler continues to hold a Overweight rating for Accenture, targeting a price of $396.<br />
&#x2A; Consistent in their evaluation, an analyst from RBC Capital keeps a Outperform rating on Accenture with a target price of $392.<br />
&#x2A; An analyst from UBS has decided to maintain their Buy rating on Accenture, which currently sits at a price target of $387.<br />
&#x2A; An analyst from BMO Capital persists with their Market Perform rating on Accenture, maintaining a target price of $370. </p>
<p>Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Accenture with <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> for real-time alerts.</p>


Decoding Accenture's Options Activity: What's the Big Picture?

<p>Deep-pocketed investors have adopted a bullish approach towards NIO (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NIO#NYSE">NIO</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in NIO usually suggests something big is about to happen.</p>
<p>We gleaned this information from our observations today when Benzinga's options scanner highlighted 20 extraordinary options activities for NIO. This level of activity is out of the ordinary.</p>
<p>The general mood among these heavyweight investors is divided, with 50% leaning bullish and 40% bearish. Among these notable options, 6 are puts, totaling $1,181,924, and 14 are calls, amounting to $831,553.</p>
<h3>Projected Price Targets</h3>
<p>After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $3.5 and $12.0 for NIO, spanning the last three months.</p>
<h3>Insights into Volume &amp; Open Interest</h3>
<p>Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for NIO's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of NIO's whale trades within a strike price range from $3.5 to $12.0 in the last 30 days. </p>
<h3>NIO 30-Day Option Volume &amp; Interest Snapshot</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1743534113_0.png" alt="Options Call Chart" /></p>
<h3>Biggest Options Spotted:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>NIO</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$8.15</td>
<td>$8.05</td>
<td>$8.15</td>
<td>$12.00</td>
<td>$668.7K</td>
<td>3.7K</td>
<td>821</td>
</tr>
<tr>
<td>NIO</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$0.64</td>
<td>$0.62</td>
<td>$0.62</td>
<td>$3.50</td>
<td>$372.0K</td>
<td>7.5K</td>
<td>6.0K</td>
</tr>
<tr>
<td>NIO</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$0.2</td>
<td>$0.19</td>
<td>$0.2</td>
<td>$5.00</td>
<td>$96.4K</td>
<td>51.3K</td>
<td>4.9K</td>
</tr>
<tr>
<td>NIO</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>11/21/25</td>
<td>$0.82</td>
<td>$0.8</td>
<td>$0.82</td>
<td>$4.00</td>
<td>$73.8K</td>
<td>4.6K</td>
<td>1.8K</td>
</tr>
<tr>
<td>NIO</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>11/21/25</td>
<td>$0.82</td>
<td>$0.8</td>
<td>$0.82</td>
<td>$4.00</td>
<td>$73.8K</td>
<td>4.6K</td>
<td>981</td>
</tr>
</tbody>
</table>
</p>
<h3>About NIO</h3>
<p>Nio is a leading electric vehicle maker, targeting the premium segment. Founded in November 2014, Nio designs, develops, jointly manufactures, and sells premium smart electric vehicles. The company differentiates itself through continuous technological breakthroughs and innovations such as battery swapping and autonomous driving technologies. Nio launched its first model, its ES8 seven-seater electric SUV, in December 2017, and began deliveries in June 2018. Its current model portfolio includes midsize to large sedans and SUVs. It sold around 222,000 EVs in 2024, accounting for about 2% of the China passenger new energy vehicle market.</p>
<p>Having examined the options trading patterns of NIO, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance</p>
<h3>Current Position of NIO</h3>
<ul>
<li>Trading volume stands at 33,092,462, with NIO's price up by 2.28%, positioned at $3.9.</li>
<li>RSI indicators show the stock to be is currently neutral between overbought and oversold.</li>
<li>Earnings announcement expected in 65 days.</li>
</ul>
<h3>Expert Opinions on NIO</h3>
<p>2 market experts have recently issued ratings for this stock, with a consensus target price of $6.15.</p>
<p><strong>Turn $1000 into $1270 in just 20 days?</strong></p>
<p>20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage"><strong>Click here for access</strong></a>.<br />
&#x2A; An analyst from Citigroup persists with their Buy rating on NIO, maintaining a target price of $8.<br />
&#x2A; Maintaining their stance, an analyst from Mizuho continues to hold a Neutral rating for NIO, targeting a price of $4. </p>
<p>Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest NIO options trades with real-time alerts from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.</p>


What the Options Market Tells Us About NIO

<p>Across the recent three months, 10 analysts have shared their insights on American International Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AIG#NYSE">AIG</a>), expressing a variety of opinions spanning from bullish to bearish.</p>
<p>The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.</p>
<table>
<thead>
<tr>
<th></th>
<th align="right"><strong>Bullish</strong></th>
<th align="right"><strong>Somewhat Bullish</strong></th>
<th align="right"><strong>Indifferent</strong></th>
<th align="right"><strong>Somewhat Bearish</strong></th>
<th align="right"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td align="right">1</td>
<td align="right">3</td>
<td align="right">6</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
<p>The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $84.8, a high estimate of $98.00, and a low estimate of $76.00. Surpassing the previous average price target of $82.30, the current average has increased by 3.04%.</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1743534099_0.png" alt="price target chart" /></p>
<h2>Exploring Analyst Ratings: An In-Depth Overview</h2>
<p>An in-depth analysis of recent analyst actions unveils how financial experts perceive American International Gr. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Alex Scott</td>
<td>Goldman Sachs</td>
<td>Raises</td>
<td>Neutral</td>
<td>$87.00</td>
<td>$79.00</td>
</tr>
<tr>
<td>Meyer Shields</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Raises</td>
<td>Outperform</td>
<td>$98.00</td>
<td>$90.00</td>
</tr>
<tr>
<td>David Motemaden</td>
<td>Evercore ISI Group</td>
<td>Raises</td>
<td>In-Line</td>
<td>$89.00</td>
<td>$81.00</td>
</tr>
<tr>
<td>Michael Zaremski</td>
<td>BMO Capital</td>
<td>Raises</td>
<td>Market Perform</td>
<td>$83.00</td>
<td>$75.00</td>
</tr>
<tr>
<td>Brian Meredith</td>
<td>UBS</td>
<td>Lowers</td>
<td>Buy</td>
<td>$86.00</td>
<td>$88.00</td>
</tr>
<tr>
<td>Meyer Shields</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Raises</td>
<td>Outperform</td>
<td>$90.00</td>
<td>$87.00</td>
</tr>
<tr>
<td>Michael Phillips</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$76.00</td>
<td>$75.00</td>
</tr>
<tr>
<td>Elyse Greenspan</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$77.00</td>
<td>$76.00</td>
</tr>
<tr>
<td>Alex Scott</td>
<td>Goldman Sachs</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$79.00</td>
<td>$83.00</td>
</tr>
<tr>
<td>Jimmy Bhullar</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$83.00</td>
<td>$89.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to American International Gr. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li><strong>Rating:</strong> Delving into assessments, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings communicate expectations for the relative performance of American International Gr compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts provide insights into price targets, offering estimates for the future value of American International Gr's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
<p>Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of American International Gr's market standing. Stay informed and make data-driven decisions with our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/AIG/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage"><strong>Stay up to date on American International Gr analyst ratings.</strong></a></p>
<h2>Delving into American International Gr's Background</h2>
<p>American International Group is one of the largest insurance and financial services firms in the world and has a global footprint. It operates through a wide range of subsidiaries that provide property, casualty, and life insurance. The company recently spun off its life insurance operations (Corebridge), but still retains a minority stake.</p>
<h3>Understanding the Numbers: American International Gr's Finances</h3>
<p><strong>Market Capitalization Highlights:</strong> Above the industry average, the company's market capitalization signifies a significant scale, indicating strong confidence and market prominence.</p>
<p><strong>Revenue Growth:</strong> American International Gr's remarkable performance in 3 months is evident. As of 31 December, 2024, the company achieved an impressive revenue growth rate of <strong>10.14%</strong>. This signifies a substantial increase in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Financials sector.</p>
<p><strong>Net Margin:</strong> American International Gr's net margin is below industry standards, pointing towards difficulties in achieving strong profitability. With a net margin of <strong>12.55%,</strong> the company may encounter challenges in effective cost control.</p>
<p><strong>Return on Equity (ROE):</strong> The company's ROE is below industry benchmarks, signaling potential difficulties in efficiently using equity capital. With an ROE of <strong>2.05%,</strong> the company may need to address challenges in generating satisfactory returns for shareholders.</p>
<p><strong>Return on Assets (ROA):</strong> American International Gr's ROA is below industry standards, pointing towards difficulties in efficiently utilizing assets. With an ROA of <strong>0.54%,</strong> the company may encounter challenges in delivering satisfactory returns from its assets.</p>
<p><strong>Debt Management:</strong> The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at <strong>0.21</strong>.</p>
<h2>The Basics of Analyst Ratings</h2>
<p>Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. </p>
<p>Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.</p>
<p><strong>Which Stocks Are Analysts Recommending Now?</strong></p>
<p>Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage"><strong>Click here to stay ahead of the market</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Analyst Ratings

10 Analysts Have This To Say About American International Gr

<p><strong>PayPal Holdings Inc. </strong>(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PYPL#NASDAQ">PYPL</a>) is on the verge of triggering <a href="https://www.benzinga.com/topic/death-cross">a <strong>Death Cross</strong></a>, a bearish technical signal where the 50-day simple moving average falls below the 200-day moving average.</p>
<p>While the stock has tumbled 23.7% year to date and 5.7% in the past month, analysts at Mizuho still see upside, maintaining an Outperform rating with a $96 price target, <a href="https://in.investing.com/news/analyst-ratings/mizuho-maintains-paypal-stock-outperform-rating-96-target-93CH-4751722">reported</a> Investing.</p>
<p><figure class="wp-block-image size-full"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0401"><img loading="lazy" decoding="async" width="631" height="489" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/01140718/Screenshot-2025-04-01-at-7.06.58-PM.png" alt="" class="wp-image-851820" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/01140718/Screenshot-2025-04-01-at-7.06.58-PM.png 631w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/01140718/Screenshot-2025-04-01-at-7.06.58-PM-300x232.png 300w" sizes="(max-width: 631px) 100vw, 631px" /></a></figure></p>
<p><em><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0401" target="_blank" rel="noreferrer noopener">Chart created using Benzinga Pro</a></em></p>
<p><strong>Read Also: <a href="https://www.benzinga.com/markets/cryptocurrency/25/03/44567164/circle-eyes-5-billion-valuation-for-upcoming-initial-public-offering">Circle Eyes $5 Billion Valuation For Upcoming Initial Public Offering</a></strong></p>
<h2 class="wp-block-heading">PayPal Stock Technicals Flash Warning Signs</h2>
<p>PayPal stock is struggling below key moving averages, reinforcing a strongly bearish trend despite signs of buying pressure. The eight-day simple moving average at $68.31 and the 20-day at $68.67 both suggest weakness, while the 50-day at $75.49 and 200-day at $75.28 highlight the broader downtrend. </p>
<p>With the Moving Average Convergence Divergence (MACD) indicator at a negative 2.21 signaling further downside risk and a Relative Strength Index (RSI) of 32.09, PayPal stock is approaching oversold territory.</p>
<h2 class="wp-block-heading">Mizuho Remains Bullish</h2>
<p>Despite PayPal stock&#8217;s technical struggles, Mizuho remains optimistic about its long-term prospects. The firm sees growth potential in Pay with Venmo, which has higher transaction margins than PayPal's traditional checkout service. With Pay with Venmo's Total Payment Volume expected to grow over 40% annually, Mizuho believes this could significantly boost overall transaction margin dollar growth.</p>
<p>PayPal's valuation stands at 17 times its estimated 2026 earnings per share, slightly above the median for legacy payments firms but still below historical levels. Mizuho argues that the company's strategic initiatives—including improvements in user experience and Fastlane adoption—justify this modest premium.</p>
<h2 class="wp-block-heading">A Path To Recovery?</h2>
<p>While a death cross looms as a bearish technical indicator, PayPal is pushing forward with growth plans. The recent appointment of <strong>Microsoft Corp</strong>'s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>) <strong>Joy Chik</strong> to the Board signals a focus on AI-driven innovation.</p>
<p>Additionally, <strong>Apple Inc</strong>'s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) decision to open its NFC chip to third-party apps could enable PayPal to expand tap-to-pay services, a potential game-changer in mobile payments.</p>
<p>For now, the trend remains bearish, but if PayPal's strategic initiatives gain traction, the stock may yet prove the skeptics wrong.</p>
<p><strong>Read Next: </strong></p>
<ul>
<li><strong><a href="https://www.benzinga.com/personal-finance/25/03/44570085/elon-musks-first-ex-wife-says-he-kept-pushing-her-to-become-a-blonde-go-platinum-and-when-filed-for-divorce-she-was-numb-but-relieved">Elon Musk&#8217;s First Ex Wife Says He Kept Pushing Her To Become a Blonde — &#8216;Go Platinum&#8217; And When Filed For Divorce, She Was Numb, &#8216;But Relieved&#8217;</a></strong></li>
</ul>


Fintech news covering the emerging Financial Technology services sector

Fintech

Technicals

Signals

Tech

MSFT

PYPL

PayPal Stock's Death Cross Looms - Will It Trigger A Turnaround?

<p>During the last three months, 11 analysts shared their evaluations of Ally Financial (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALLY#NYSE">ALLY</a>), revealing diverse outlooks from bullish to bearish.</p>
<p>The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.</p>
<table>
<thead>
<tr>
<th></th>
<th align="right"><strong>Bullish</strong></th>
<th align="right"><strong>Somewhat Bullish</strong></th>
<th align="right"><strong>Indifferent</strong></th>
<th align="right"><strong>Somewhat Bearish</strong></th>
<th align="right"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td align="right">4</td>
<td align="right">4</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td align="right">3</td>
<td align="right">4</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
<p>Insights from analysts' 12-month price targets are revealed, presenting an average target of $43.45, a high estimate of $50.00, and a low estimate of $34.00. Observing a 9.72% increase, the current average has risen from the previous average price target of $39.60. </p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1743534091_0.png" alt="price target chart" /></p>
<h2>Interpreting Analyst Ratings: A Closer Look</h2>
<p>An in-depth analysis of recent analyst actions unveils how financial experts perceive Ally Financial. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Ryan Nash</td>
<td>Goldman Sachs</td>
<td>Raises</td>
<td>Buy</td>
<td>$50.00</td>
<td>$45.00</td>
</tr>
<tr>
<td>David Smith</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$47.00</td>
<td>$42.00</td>
</tr>
<tr>
<td>Betsy Graseck</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Overweight</td>
<td>$45.00</td>
<td>$41.00</td>
</tr>
<tr>
<td>Richard Shane</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Overweight</td>
<td>$43.00</td>
<td>$40.00</td>
</tr>
<tr>
<td>Karl Shepard</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Outperform</td>
<td>$45.00</td>
<td>$41.00</td>
</tr>
<tr>
<td>Ryan Nash</td>
<td>Goldman Sachs</td>
<td>Raises</td>
<td>Buy</td>
<td>$48.00</td>
<td>$42.00</td>
</tr>
<tr>
<td>Donald Fandetti</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Underweight</td>
<td>$34.00</td>
<td>$32.00</td>
</tr>
<tr>
<td>John Hecht</td>
<td>Jefferies</td>
<td>Raises</td>
<td>Hold</td>
<td>$40.00</td>
<td>$35.00</td>
</tr>
<tr>
<td>Richard Shane</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$40.00</td>
<td>$42.00</td>
</tr>
<tr>
<td>David Smith</td>
<td>Truist Securities</td>
<td>Announces</td>
<td>Buy</td>
<td>$42.00</td>
<td>-</td>
</tr>
<tr>
<td>Jason Goldberg</td>
<td>Barclays</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$44.00</td>
<td>$36.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Ally Financial. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li><strong>Rating:</strong> Analyzing trends, analysts offer qualitative evaluations, ranging from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Ally Financial compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts explore the dynamics of price targets, providing estimates for the future value of Ally Financial's stock. This examination reveals shifts in analysts' expectations over time.</li>
</ul>
<p>For valuable insights into Ally Financial's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/ALLY/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage"><strong>Stay up to date on Ally Financial analyst ratings.</strong></a></p>
<h2>Delving into Ally Financial's Background</h2>
<p>Formerly the captive financial arm of General Motors, Ally Financial became an independent publicly traded firm in 2014 and is one of the largest consumer auto lenders in the country. While the firm has expanded its product offerings over time, it remains primarily focused on auto lending, with more than 70% of its loan book in consumer auto loans and dealer financing. Ally also offers auto insurance, commercial loans, credit cards, and holds a portfolio of mortgage debt, giving the bank a diversified business model, which includes brokerage services.</p>
<h3>Ally Financial's Financial Performance</h3>
<p><strong>Market Capitalization:</strong> Indicating a reduced size compared to industry averages, the company's market capitalization poses unique challenges.</p>
<p><strong>Revenue Challenges:</strong> Ally Financial's revenue growth over 3 months faced difficulties. As of 31 December, 2024, the company experienced a decline of approximately <strong>-2.18%</strong>. This indicates a decrease in top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Financials sector.</p>
<p><strong>Net Margin:</strong> Ally Financial's net margin is below industry standards, pointing towards difficulties in achieving strong profitability. With a net margin of <strong>-7.46%,</strong> the company may encounter challenges in effective cost control.</p>
<p><strong>Return on Equity (ROE):</strong> The company's ROE is below industry benchmarks, signaling potential difficulties in efficiently using equity capital. With an ROE of <strong>-1.39%,</strong> the company may need to address challenges in generating satisfactory returns for shareholders.</p>
<p><strong>Return on Assets (ROA):</strong> The company's ROA is below industry benchmarks, signaling potential difficulties in efficiently utilizing assets. With an ROA of <strong>-0.09%,</strong> the company may need to address challenges in generating satisfactory returns from its assets.</p>
<p><strong>Debt Management:</strong> With a below-average debt-to-equity ratio of <strong>1.66</strong>, Ally Financial adopts a prudent financial strategy, indicating a balanced approach to debt management.</p>
<h2>How Are Analyst Ratings Determined?</h2>
<p>Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.</p>
<p>Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.</p>
<p><strong>Which Stocks Are Analysts Recommending Now?</strong></p>
<p>Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage"><strong>Click here to stay ahead of the market</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


ALLY

The Analyst Verdict: Ally Financial In The Eyes Of 11 Experts

<p>Ratings for Travere Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TVTX#NASDAQ">TVTX</a>) were provided by 7 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.</p>
<p>The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th align="right"><strong>Bullish</strong></th>
<th align="right"><strong>Somewhat Bullish</strong></th>
<th align="right"><strong>Indifferent</strong></th>
<th align="right"><strong>Somewhat Bearish</strong></th>
<th align="right"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td align="right">4</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td align="right">2</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
<p>Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $36.29, with a high estimate of $45.00 and a low estimate of $22.00. Marking an increase of 25.74%, the current average surpasses the previous average price target of $28.86. </p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1743534083_0.png" alt="price target chart" /></p>
<h2>Exploring Analyst Ratings: An In-Depth Overview</h2>
<p>The standing of Travere Therapeutics among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Greg Harrison</td>
<td>B of A Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$31.00</td>
<td>$29.00</td>
</tr>
<tr>
<td>Anupam Rama</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Overweight</td>
<td>$44.00</td>
<td>$42.00</td>
</tr>
<tr>
<td>Carly Kenselaar</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Buy</td>
<td>$35.00</td>
<td>$31.00</td>
</tr>
<tr>
<td>Greg Harrison</td>
<td>Scotiabank</td>
<td>Raises</td>
<td>Sector Outperform</td>
<td>$32.00</td>
<td>$27.00</td>
</tr>
<tr>
<td>Liisa Bayko</td>
<td>Evercore ISI Group</td>
<td>Raises</td>
<td>Outperform</td>
<td>$45.00</td>
<td>$33.00</td>
</tr>
<tr>
<td>Edward Nash</td>
<td>Canaccord Genuity</td>
<td>Raises</td>
<td>Buy</td>
<td>$45.00</td>
<td>$22.00</td>
</tr>
<tr>
<td>Ed Arce</td>
<td>HC Wainwright &amp; Co.</td>
<td>Raises</td>
<td>Buy</td>
<td>$22.00</td>
<td>$18.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Travere Therapeutics. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li><strong>Rating:</strong> Analyzing trends, analysts offer qualitative evaluations, ranging from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Travere Therapeutics compared to the broader market.</li>
<li><strong>Price Targets:</strong> Understanding forecasts, analysts offer estimates for Travere Therapeutics's future value. Examining the current and prior targets provides insight into analysts' changing expectations.</li>
</ul>
<p>Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of Travere Therapeutics's market standing. Stay informed and make data-driven decisions with our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/TVTX/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage"><strong>Stay up to date on Travere Therapeutics analyst ratings.</strong></a></p>
<p>If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">you can start by tracking it here</a>.</p>
<h2>Get to Know Travere Therapeutics Better</h2>
<p>Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.</p>
<h3>Travere Therapeutics: Delving into Financials</h3>
<p><strong>Market Capitalization:</strong> Positioned above industry average, the company's market capitalization underscores its superiority in size, indicative of a strong market presence.</p>
<p><strong>Revenue Growth:</strong> Over the 3 months period, Travere Therapeutics showcased positive performance, achieving a revenue growth rate of <strong>65.98%</strong> as of 31 December, 2024. This reflects a substantial increase in the company's top-line earnings. When compared to others in the Health Care sector, the company faces challenges, achieving a growth rate lower than the average among peers.</p>
<p><strong>Net Margin:</strong> Travere Therapeutics's net margin is impressive, surpassing industry averages. With a net margin of <strong>-80.58%,</strong> the company demonstrates strong profitability and effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> Travere Therapeutics's ROE lags behind industry averages, suggesting challenges in maximizing returns on equity capital. With an ROE of <strong>-421.09%,</strong> the company may face hurdles in achieving optimal financial performance.</p>
<p><strong>Return on Assets (ROA):</strong> Travere Therapeutics's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of <strong>-10.97%,</strong> the company may face hurdles in achieving optimal financial returns.</p>
<p><strong>Debt Management:</strong> Travere Therapeutics's debt-to-equity ratio is notably higher than the industry average. With a ratio of <b>6.8</b>, the company relies more heavily on borrowed funds, indicating a higher level of financial risk.</p>
<h2>What Are Analyst Ratings?</h2>
<p>Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.</p>
<p>Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.</p>
<p><strong>Which Stocks Are Analysts Recommending Now?</strong></p>
<p>Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage"><strong>Click here to stay ahead of the market</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


TVTX

The Analyst Verdict: Travere Therapeutics In The Eyes Of 7 Experts

<p>6 analysts have expressed a variety of opinions on Safehold (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAFE#NYSE">SAFE</a>) over the past quarter, offering a diverse set of opinions from bullish to bearish.</p>
<p>The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th align="right"><strong>Bullish</strong></th>
<th align="right"><strong>Somewhat Bullish</strong></th>
<th align="right"><strong>Indifferent</strong></th>
<th align="right"><strong>Somewhat Bearish</strong></th>
<th align="right"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
<p>Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $24.83, along with a high estimate of $35.00 and a low estimate of $19.00. This current average represents a 11.86% decrease from the previous average price target of $28.17. </p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1743534063_0.png" alt="price target chart" /></p>
<h2>Breaking Down Analyst Ratings: A Detailed Examination</h2>
<p>The analysis of recent analyst actions sheds light on the perception of Safehold by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Richard Anderson</td>
<td>Wedbush</td>
<td>Maintains</td>
<td>Neutral</td>
<td>$20.00</td>
<td>$20.00</td>
</tr>
<tr>
<td>Mitch Germain</td>
<td>JMP Securities</td>
<td>Lowers</td>
<td>Market Outperform</td>
<td>$32.00</td>
<td>$35.00</td>
</tr>
<tr>
<td>Richard Anderson</td>
<td>Wedbush</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$19.00</td>
<td>$20.00</td>
</tr>
<tr>
<td>Mitch Germain</td>
<td>JMP Securities</td>
<td>Maintains</td>
<td>Market Outperform</td>
<td>$35.00</td>
<td>$35.00</td>
</tr>
<tr>
<td>Richard Hill</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$19.00</td>
<td>$30.00</td>
</tr>
<tr>
<td>Caitlin Burrows</td>
<td>Goldman Sachs</td>
<td>Lowers</td>
<td>Buy</td>
<td>$24.00</td>
<td>$29.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Safehold. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li><strong>Rating:</strong> Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Safehold compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts provide insights into price targets, offering estimates for the future value of Safehold's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
<p>Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of Safehold's market standing. Stay informed and make data-driven decisions with our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/SAFE/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage"><strong>Stay up to date on Safehold analyst ratings.</strong></a></p>
<p>If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">you can start by tracking it here</a>.</p>
<h2>Unveiling the Story Behind Safehold</h2>
<p>Safehold Inc is a REIT that operates its business by acquiring, managing, and capitalizing ground leases. Ground leases are long-term contracts between the landlord (the Company) and a tenant or leaseholder. Ground leases generally represent ownership of the land underlying commercial real estate projects that are net leased by the fee owner of the land to the owners/operators of the real estate projects built thereon.</p>
<h3>Unraveling the Financial Story of Safehold</h3>
<p><strong>Market Capitalization Analysis:</strong> Falling below industry benchmarks, the company's market capitalization reflects a reduced size compared to peers. This positioning may be influenced by factors such as growth expectations or operational capacity.</p>
<p><strong>Negative Revenue Trend:</strong> Examining Safehold's financials over 3 months reveals challenges. As of 31 December, 2024, the company experienced a decline of approximately <strong>-10.83%</strong> in revenue growth, reflecting a decrease in top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Real Estate sector.</p>
<p><strong>Net Margin:</strong> Safehold's net margin lags behind industry averages, suggesting challenges in maintaining strong profitability. With a net margin of <strong>28.34%,</strong> the company may face hurdles in effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> Safehold's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of <strong>1.12%,</strong> the company showcases efficient use of equity capital and strong financial health.</p>
<p><strong>Return on Assets (ROA):</strong> Safehold's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of <strong>0.38%,</strong> the company may face hurdles in achieving optimal financial performance.</p>
<p><strong>Debt Management:</strong> Safehold's debt-to-equity ratio is below the industry average at <strong>1.8</strong>, reflecting a lower dependency on debt financing and a more conservative financial approach.</p>
<h2>Understanding the Relevance of Analyst Ratings</h2>
<p>Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. </p>
<p>Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.</p>
<p><strong>Breaking: Wall Street's Next Big Mover</strong></p>
<p>Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag"><strong>Click here for urgent details</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


SAFE

Deep Dive Into Safehold Stock: Analyst Perspectives (6 Ratings)

<p>Analysts' ratings for CarMax (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KMX#NYSE">KMX</a>) over the last quarter vary from bullish to bearish, as provided by 4 analysts.</p>
<p>The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th align="right"><strong>Bullish</strong></th>
<th align="right"><strong>Somewhat Bullish</strong></th>
<th align="right"><strong>Indifferent</strong></th>
<th align="right"><strong>Somewhat Bearish</strong></th>
<th align="right"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
<p>Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $92.75, a high estimate of $105.00, and a low estimate of $65.00. This current average has decreased by 1.59% from the previous average price target of $94.25. </p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1743534049_0.png" alt="price target chart" /></p>
<h2>Understanding Analyst Ratings: A Comprehensive Breakdown</h2>
<p>An in-depth analysis of recent analyst actions unveils how financial experts perceive CarMax. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Seth Basham</td>
<td>Wedbush</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$100.00</td>
<td>$100.00</td>
</tr>
<tr>
<td>Rajat Gupta</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Underweight</td>
<td>$65.00</td>
<td>$72.00</td>
</tr>
<tr>
<td>Michael Montani</td>
<td>Evercore ISI Group</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$105.00</td>
<td>$107.00</td>
</tr>
<tr>
<td>Chris Pierce</td>
<td>Needham</td>
<td>Raises</td>
<td>Buy</td>
<td>$101.00</td>
<td>$98.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to CarMax. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li><strong>Rating:</strong> Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of CarMax compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts explore the dynamics of price targets, providing estimates for the future value of CarMax's stock. This examination reveals shifts in analysts' expectations over time.</li>
</ul>
<p>Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of CarMax's market position. Stay informed and make well-informed decisions with our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/KMX/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage"><strong>Stay up to date on CarMax analyst ratings.</strong></a></p>
<h2>Get to Know CarMax Better</h2>
<p>CarMax sells, finances, and services used and new cars through a chain of around 250 used retail stores. It was formed in 1993 as a unit of Circuit City and spun off into an independent company in late 2002. Used-vehicle sales typically account for about 83% of revenue (79% in fiscal 2024 due to the chip shortage) and wholesale about 13% (19% in fiscal 2024), with the remaining portion composed of extended service plans and repair. In fiscal 2024, the company retailed and wholesaled 765,572, and 546,331 used vehicles, respectively. CarMax is the largest used-vehicle retailer in the US but still estimates that it had only about 3.7% US market share of vehicles 0-10 years old in 2023. It seeks over 5% share a few years from now. CarMax is based in Richmond, Virginia.</p>
<h3>CarMax: Financial Performance Dissected</h3>
<p><strong>Market Capitalization Highlights:</strong> Above the industry average, the company's market capitalization signifies a significant scale, indicating strong confidence and market prominence.</p>
<p><strong>Revenue Growth:</strong> Over the 3 months period, CarMax showcased positive performance, achieving a revenue growth rate of <strong>1.22%</strong> as of 30 November, 2024. This reflects a substantial increase in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Consumer Discretionary sector.</p>
<p><strong>Net Margin:</strong> CarMax's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of <strong>2.02%,</strong> the company showcases strong profitability and effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> CarMax's ROE stands out, surpassing industry averages. With an impressive ROE of <strong>2.02%</strong>, the company demonstrates effective use of equity capital and strong financial performance.</p>
<p><strong>Return on Assets (ROA):</strong> CarMax's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of <strong>0.46%,</strong> the company showcases efficient use of assets and strong financial health.</p>
<p><strong>Debt Management:</strong> CarMax's debt-to-equity ratio is below the industry average. With a ratio of <b>3.09</b>, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.</p>
<h2>How Are Analyst Ratings Determined?</h2>
<p>Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.</p>
<p>Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.</p>
<p><strong>Breaking: Wall Street's Next Big Mover</strong></p>
<p>Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag"><strong>Click here for urgent details</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Comments

Amentum Holdings

Amentum Holdings (AMTM) Options

Amentum Holdings (NYSE:AMTM) Stock, Chaîne d'Options

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL